Skip to main content
Equibles

MORGAN STANLEY

Position in INO — Inovio Pharmaceuticals, Inc.

CIK 895421 NEW YORK, NY
Back to INO Full portfolio

Position in INO

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$55,279
-$55,842 QoQ
Shares Held
50,256
-21.3% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#31
of 101 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 11% Shared 0% None 89%

Common Shares in INO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. INO ranks #372 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in INO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $55,279 50,256
2026-03-31 $111,121 63,864
2025-12-31 $184,138 105,828
2025-09-30 $1,841,049 786,774
2025-06-30 $819,795 401,862
2025-03-31 $463,964 284,643
2024-12-31 $243,894 133,277
2024-09-30 $549,861 95,132
2024-06-30 $837,942 103,706
2024-03-31 $955,968 68,874
2023-12-31 $276,263 541,696
2023-09-30 $118,649 304,237
2023-06-30 $169,501 376,677
2023-03-31 $425,393 518,776
2022-12-31 $1,961,663 1,257,479
2022-09-30 $2,236,629 1,292,852
2022-06-30 $4,717,861 2,727,089
2022-03-31 $5,938,972 1,654,311
2021-12-31 $2,622,141 525,480
2021-09-30 $5,279,680 737,386
2021-06-30 $7,694,654 830,060
2021-03-31 $2,696,680 290,591
2020-12-31 $5,107,170 577,082
2020-09-30 $7,458,633 642,986
2020-06-30 $7,404,699 274,757
2020-03-31 $1,701,905 228,751